Sovianne Ter Borg1, Lisette C P G M de Groot2, Donja M Mijnarends3, Jeanne H M de Vries2, Sjors Verlaan4, Saskia Meijboom2, Yvette C Luiking5, Jos M G A Schols6. 1. Nutricia Research, Nutricia Advanced Medical Nutrition, Utrecht, The Netherlands. Electronic address: sovianne.terborg@nutricia.com. 2. Wageningen University, Division of Human Nutrition, Wageningen, The Netherlands. 3. School CAPHRI, Department of Health Services Research, Maastricht University, Maastricht, The Netherlands. 4. Nutricia Research, Nutricia Advanced Medical Nutrition, Utrecht, The Netherlands. 5. Nutricia Research, Nutricia Advanced Medical Nutrition, Utrecht, The Netherlands; Center for Translational Research in Aging and Longevity, Department of Health and Kinesiology, Texas A and M University, College Station, TX. 6. School CAPHRI, Department of Family Medicine, Maastricht University, Maastricht, The Netherlands.
Abstract
BACKGROUND: There is growing evidence of a relationship between nutrients and muscle mass, strength, and physical performance. Although nutrition is seen as an important pillar of treating sarcopenia, data on the nutritional intake of sarcopenic older adults are limited. OBJECTIVE: To investigate potential nutritional gaps in the sarcopenic population, the present study compared nutrient intake and biochemical nutrient status between sarcopenic and nonsarcopenic older adults. DESIGN: The Maastricht Sarcopenia Study included 227 community-dwelling older adults (≥65 years) from Maastricht, 53 of whom were sarcopenic based on the European Working Group on Sarcopenia in Older People algorithm. Habitual dietary intake was assessed with a food frequency questionnaire and data on dietary supplement use were collected. In addition, serum 25-hydroxyvitamin D, magnesium and α-tocopherol/cholesterol, plasma homocysteine and red blood cell n-3, and n-6 fatty acids profiles were assessed. Nutrient intake and biochemical nutrient status of the sarcopenic groups were compared with those of the nonsarcopenic groups. The robustness of these results was tested with a multiple regression analysis, taking into account between-group differences in characteristics. RESULTS: Sarcopenic older adults had a 10%-18% lower intake of 5 nutrients (n-3 fatty acids, vitamin B6, folic acid, vitamin E, magnesium) compared with nonsarcopenic older adults (P < .05). When taking into account dietary supplement intake, a 19% difference remained for n-3 fatty acids intake (P = .005). For the 2 biochemical status markers, linoleic acid and homocysteine, a 7% and 27% difference was observed, respectively (P < .05). The higher homocysteine level confirmed the observed lower vitamin B intake in the sarcopenic group. Observed differences in eicosapentaenoic acid and 25-hydroxyvitamin D between the groups were related to differences in age and living situation. CONCLUSIONS: Sarcopenic older adults differed in certain nutritional intakes and biochemical nutrient status compared with nonsarcopenic older adults. Dietary supplement intake reduced the gap for some of these nutrients. Targeted nutritional intervention may therefore improve the nutritional intake and biochemical status of sarcopenic older adults.
BACKGROUND: There is growing evidence of a relationship between nutrients and muscle mass, strength, and physical performance. Although nutrition is seen as an important pillar of treating sarcopenia, data on the nutritional intake of sarcopenic older adults are limited. OBJECTIVE: To investigate potential nutritional gaps in the sarcopenic population, the present study compared nutrient intake and biochemical nutrient status between sarcopenic and nonsarcopenic older adults. DESIGN: The Maastricht Sarcopenia Study included 227 community-dwelling older adults (≥65 years) from Maastricht, 53 of whom were sarcopenic based on the European Working Group on Sarcopenia in Older People algorithm. Habitual dietary intake was assessed with a food frequency questionnaire and data on dietary supplement use were collected. In addition, serum 25-hydroxyvitamin D, magnesium and α-tocopherol/cholesterol, plasma homocysteine and red blood cell n-3, and n-6 fatty acids profiles were assessed. Nutrient intake and biochemical nutrient status of the sarcopenic groups were compared with those of the nonsarcopenic groups. The robustness of these results was tested with a multiple regression analysis, taking into account between-group differences in characteristics. RESULTS:Sarcopenic older adults had a 10%-18% lower intake of 5 nutrients (n-3 fatty acids, vitamin B6, folic acid, vitamin E, magnesium) compared with nonsarcopenic older adults (P < .05). When taking into account dietary supplement intake, a 19% difference remained for n-3 fatty acids intake (P = .005). For the 2 biochemical status markers, linoleic acid and homocysteine, a 7% and 27% difference was observed, respectively (P < .05). The higher homocysteine level confirmed the observed lower vitamin B intake in the sarcopenic group. Observed differences in eicosapentaenoic acid and 25-hydroxyvitamin D between the groups were related to differences in age and living situation. CONCLUSIONS:Sarcopenic older adults differed in certain nutritional intakes and biochemical nutrient status compared with nonsarcopenic older adults. Dietary supplement intake reduced the gap for some of these nutrients. Targeted nutritional intervention may therefore improve the nutritional intake and biochemical status of sarcopenic older adults.
Authors: S Ter Borg; Y C Luiking; A van Helvoort; Y Boirie; J M G A Schols; C P G M de Groot Journal: J Nutr Health Aging Date: 2019 Impact factor: 4.075
Authors: Pariya Behrouzi; Pol Grootswagers; Paul L C Keizer; Ellen T H C Smeets; Edith J M Feskens; Lisette C P G M de Groot; Fred A van Eeuwijk Journal: J Nutr Date: 2020-03-01 Impact factor: 4.798
Authors: Fedra Luciano-Mateo; Anna Hernández-Aguilera; Noemi Cabre; Jordi Camps; Salvador Fernández-Arroyo; Jose Lopez-Miranda; Javier A Menendez; Jorge Joven Journal: Nutrients Date: 2017-02-10 Impact factor: 5.717
Authors: Olaf Verschuren; Ana R P Smorenburg; Yvette Luiking; Kristie Bell; Lee Barber; Mark D Peterson Journal: J Cachexia Sarcopenia Muscle Date: 2018-02-02 Impact factor: 12.910